- Home
- NKSH vs TVGN Comparison
NKSH vs TVGN Comparison
Compare NKSH & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- TVGN
- Stock Information
- Founded
- NKSH 1891
- TVGN 2020
- Country
- NKSH United States
- TVGN United States
- Employees
- NKSH N/A
- TVGN N/A
- Industry
- NKSH Major Banks
- TVGN Blank Checks
- Sector
- NKSH Finance
- TVGN Finance
- Exchange
- NKSH Nasdaq
- TVGN Nasdaq
- Market Cap
- NKSH 185.4M
- TVGN 174.4M
- IPO Year
- NKSH N/A
- TVGN N/A
- Fundamental
- Price
- NKSH $29.34
- TVGN $1.35
- Analyst Decision
- NKSH Strong Buy
- TVGN
- Analyst Count
- NKSH 1
- TVGN 0
- Target Price
- NKSH $38.00
- TVGN N/A
- AVG Volume (30 Days)
- NKSH 12.4K
- TVGN 1.7M
- Earning Date
- NKSH 03-18-2025
- TVGN 02-20-2025
- Dividend Yield
- NKSH 5.17%
- TVGN N/A
- EPS Growth
- NKSH N/A
- TVGN N/A
- EPS
- NKSH 1.24
- TVGN N/A
- Revenue
- NKSH $44,130,000.00
- TVGN N/A
- Revenue This Year
- NKSH N/A
- TVGN N/A
- Revenue Next Year
- NKSH $19.72
- TVGN N/A
- P/E Ratio
- NKSH $23.71
- TVGN N/A
- Revenue Growth
- NKSH N/A
- TVGN N/A
- 52 Week Low
- NKSH $26.00
- TVGN $0.26
- 52 Week High
- NKSH $35.00
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- NKSH 50.86
- TVGN 55.34
- Support Level
- NKSH $26.00
- TVGN $1.24
- Resistance Level
- NKSH $30.71
- TVGN $1.57
- Average True Range (ATR)
- NKSH 1.01
- TVGN 0.17
- MACD
- NKSH 0.30
- TVGN 0.02
- Stochastic Oscillator
- NKSH 70.91
- TVGN 58.49
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.